Dr. Anita Mathias currently holds the position of Vice President, Clinical Pharmacology and Development, Gossamer Bio, San Diego, CA. She received her Ph.D. from the Department of Pharmaceutics, University of Washington in 2004 and joined the Department of Pharmaceutics, University of Washington as an affiliate professor in 2020. In her role at Gossamer Bio, she is responsible for early clinical drug development including lead candidate dose selection, establishing proof-of concept, safety, and late-stage clinical development programs in the disease areas of Immunology, Inflammation, and Oncology. Prior to joining Gossamer Bio, Anita was Executive Director, Head of Clinical and Quantitative Pharmacology Department at Gilead Sciences, Inc., where over a 15-year tenure, she built a scientific team who were responsible for supporting clinicalpharmacokinetics, translational medicine, early and late drug development strategy and regulatory filings for compounds in the areas of Hematology, Immunology, Infectious Disease, Liver Disease and Oncology. Anita and her team worked on several molecules that culminated in 12 global regulatory approvals. In conjunction with this work, Anita has coached, mentored, and developed numerous Clinical Pharmacologists and Drug Developers. She is a co-author of over 40 research articles and has presented at multiple national and international conferences. Anita is also involved in inclusion initiatives, with Women in Science and various STEAM events, focused on career development, interpersonal and professional enrichment for young adults and women.